A.JasmineJinitha 1
, Rexline S.J.2
Section:Research Paper, Product Type: Journal Paper
Volume-07 ,
Issue-05 , Page no. 186-190, Mar-2019
CrossRef-DOI:
https://doi.org/10.26438/ijcse/v7si5.186190
Online published on Mar 10, 2019
Copyright © A.JasmineJinitha, Rexline S.J. . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
View this paper at
Google Scholar |
DPI Digital Library
- IEEE Citation
- MLA Citation
- APA Citation
- BibTex Citation
- RIS Citation
IEEE Style Citation: A.JasmineJinitha, Rexline S.J., “Pharmacovigilance: An Essential Tool for Drug Safety Monitoring,” International Journal of Computer Sciences and Engineering, Vol.07, Issue.05, pp.186-190, 2019.
MLA Style Citation: A.JasmineJinitha, Rexline S.J. "Pharmacovigilance: An Essential Tool for Drug Safety Monitoring." International Journal of Computer Sciences and Engineering 07.05 (2019): 186-190.
APA Style Citation: A.JasmineJinitha, Rexline S.J., (2019). Pharmacovigilance: An Essential Tool for Drug Safety Monitoring. International Journal of Computer Sciences and Engineering, 07(05), 186-190.
BibTex Style Citation:
@article{S.J._2019,
author = {A.JasmineJinitha, Rexline S.J.},
title = {Pharmacovigilance: An Essential Tool for Drug Safety Monitoring},
journal = {International Journal of Computer Sciences and Engineering},
issue_date = {3 2019},
volume = {07},
Issue = {05},
month = {3},
year = {2019},
issn = {2347-2693},
pages = {186-190},
url = {https://www.ijcseonline.org/full_spl_paper_view.php?paper_id=829},
doi = {https://doi.org/10.26438/ijcse/v7i5.186190}
publisher = {IJCSE, Indore, INDIA},
}
RIS Style Citation:
TY - JOUR
DO = {https://doi.org/10.26438/ijcse/v7i5.186190}
UR - https://www.ijcseonline.org/full_spl_paper_view.php?paper_id=829
TI - Pharmacovigilance: An Essential Tool for Drug Safety Monitoring
T2 - International Journal of Computer Sciences and Engineering
AU - A.JasmineJinitha, Rexline S.J.
PY - 2019
DA - 2019/03/10
PB - IJCSE, Indore, INDIA
SP - 186-190
IS - 05
VL - 07
SN - 2347-2693
ER -
Pharmacovigilance(PV) is the science and activities relating to the detection , assessment, understanding and prevention of adverse effects. Adverse effects means the abnormal conditions occurs in the body due to the drugs which are consumed by the peoples. The main process of pharmacovigilance is reporting about the safety and quality of the drugs. It makes the treatment for patients as worthy as possible. This process makes the subject of chemical compositions of the drugs worthy and correctly. This is one of the major process in drug industries. The proposed system use an ideal tool for this process is the reporting by means of forms which are available under medical bodies also by means of web applications for pharmacovigilance process. This paper presents the better results in clinical trials. The success or failure of pharmacovigilance activity depends on the reporting of suspected adverse reactions. Reports made by a health professional are an interpretation of information originally provided by a patient who has experienced the actual benefit or harm of a medicine taken.
adverse reactions, adverse effects, drugs, pharmacovigilance
[1] Overview of Pharmacovigilance Research & Reviews: Journal of Pharmacology and Toxicological Studies/ Amarendra KE Research & Reviews: Journal of Pharmacology and Toxicological Studies e-ISSN: 2319-9873
[2] The Safety of Medicines in Public Health Programmes Pharmacovigilance: an essential tool World Health Organization. ISBN 92 4 159391 1
[3] Dr Arvind Mathur, “WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance”,World Health Organisation
[4] World Health Organization. “Pharmacovigilance: Ensuring the safe use of medicines” Oct 2004
[5] GeetaSharma,RahathKumar.”Pharmacovigilance in India and its impact in patient Management”. The Journal of current trends in Diagnosis and Treatment, 2017, 27-33
[6] “The Uppsala monitoring system”, WHO Collaborating Centre for International Drug Monitoring World Health Organization.
[7] Indian journal of pharmacology volume 50(2); mar-apr 2018
[8] Joerg H. Basic Principles of Pharmacovigilance and Data Sources.
[9] SachdevY.“Pharmacovigilance:SafetyMatters”,IndianPharmacology.2008,vol40, Supplement 1,s13-s16
[10] Kumar A. “ Past, Present and future of Pharmacovigilance in India”. Syst Rev Pharm 2011 2(1),55-58
[11] Naranjo CA, Busto U, Sellers EM, Sandor P, Ruis I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin PharmacolTher. 1981;30:239–45.
[12] Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.
